Literature DB >> 12379768

Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63.

Marco Chilosi1, Venerino Poletti, Bruno Murer, Maurizio Lestani, Alessandra Cancellieri, Licia Montagna, Paola Piccoli, Giulia Cangi, Gianpietro Semenzato, Claudio Doglioni.   

Abstract

Products of the p63 gene, a recently described member of the p53 family, are constitutively expressed in the basal cells of human bronchi and bronchioli. The truncated isoforms of the p63 gene (deltaN-p63 proteins) counteract the apoptotic and cell cycle inhibitory functions of p53 after DNA damage, and this property is likely to be central in the cell renewal strategy of stratified epithelial tissues. To investigate the dysfunctional repair processes that characterize idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP), we immunohistochemically analyzed the expression of the transactivating and dominant-negative isoforms of the p63 gene on 16 tissue samples obtained from patients suffering from this disorder. In most IPF cases herein investigated, epithelial cells expressing deltaN-p63 were observed at sites of abnormal proliferation at the bronchiolo-alveolar junctions, characterized by epithelial hyperplasia, squamous metaplasia, bronchiolization, and abnormal p53 nuclear accumulation. Similar features were not observed in normal lung and in samples taken from other pulmonary diseases used as controls, including acute interstitial pneumonia, idiopathic bronchiolitis obliterans organizing pneumonia, nonspecific interstitial pneumonia, and desquamative interstitial pneumonia. On the basis of these findings, we can hypothesize a new model for UIP pathogenesis, involving a deregulated development of mesenchymal-epithelial interactions and abnormal proliferation of epithelial cells at the bronchiolo-alveolar junction after cell injury. In our view, the progressive loss of alveolar tissue and lung remodeling after injury in IPF/UIP is concomitantly produced by pneumocyte loss and alveolar collapse on one hand and by progressive bronchiolar proliferation and architectural distortion on the other.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379768     DOI: 10.1097/01.lab.0000032380.82232.67

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  74 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

Review 2.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 4.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

Review 5.  Genetic susceptibility and pulmonary fibrosis.

Authors:  Susan K Mathai; David A Schwartz; Laura A Warg
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 6.  Lung development: orchestrating the generation and regeneration of a complex organ.

Authors:  Michael Herriges; Edward E Morrisey
Journal:  Development       Date:  2014-02       Impact factor: 6.868

7.  Altered expression of p63 isoforms and expansion of p63- and club cell secretory protein-positive epithelial cells in the lung as novel features of aging.

Authors:  Jutaro Fukumoto; Sahebgowda Sidramagowda Patil; Sudarshan Krishnamurthy; Smita Saji; Irene John; Venkata Ramireddy Narala; Helena Hernández-Cuervo; Matthew Alleyn; Mason T Breitzig; Lakshmi Galam; Ramani Soundararajan; Uddhav K Chaudhari; Barbara C Hansen; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2019-01-16       Impact factor: 4.249

8.  BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.

Authors:  Antje Prasse; Harald Binder; Jonas C Schupp; Gian Kayser; Elena Bargagli; Benedikt Jaeger; Moritz Hess; Susanne Rittinghausen; Louis Vuga; Heather Lynn; Shelia Violette; Birgit Jung; Karsten Quast; Bart Vanaudenaerde; Yan Xu; Jens M Hohlfeld; Norbert Krug; Jose D Herazo-Maya; Paola Rottoli; Wim A Wuyts; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2019-03-01       Impact factor: 21.405

9.  WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Monika Kramer; Nisha Balsara; Jochen Wilhelm; Oana Veronica Amarie; Andreas Jahn; Frank Rose; Ludger Fink; Werner Seeger; Liliana Schaefer; Andreas Günther; Oliver Eickelberg
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

10.  Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats.

Authors:  Sarah J Bolton; Kate Pinnion; Victor Oreffo; Martyn Foster; Kent E Pinkerton
Journal:  Respir Res       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.